Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
Sekino Y, Takemoto K, Murata D, Babasaki T, Kobatake K, Kitano H, Ikeda K, Goto K, Inoue S, Hayashi T, Taniyama D, Shigeta M, Kuraoka K, Mita K, Kaneko M, Sentani K, Oue N, Teishima J. Sekino Y, et al. Among authors: taniyama d. Anticancer Res. 2021 Oct;41(10):4875-4883. doi: 10.21873/anticanres.15301. Anticancer Res. 2021. PMID: 34593435
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma.
Sekino Y, Hagura T, Han X, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shigeta M, Taniyama D, Kuraoka K, Sentani K, Yasui W, Matsubara A. Sekino Y, et al. Among authors: taniyama d. Anticancer Res. 2020 Apr;40(4):1943-1951. doi: 10.21873/anticanres.14149. Anticancer Res. 2020. PMID: 32234883
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma.
Pham QT, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, Sakamoto N, Sentani K, Oue N, Yasui W. Pham QT, et al. Among authors: taniyama d. BMC Cancer. 2021 Jun 26;21(1):737. doi: 10.1186/s12885-021-08477-1. BMC Cancer. 2021. PMID: 34174844 Free PMC article.
P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
Sekino Y, Takemoto K, Murata D, Babasaki T, Kobatake K, Kitano H, Ikeda K, Goto K, Inoue S, Hayashi T, Taniyama D, Shigeta M, Kuraoka K, Mita K, Kaneko M, Sentani K, Oue N, Teishima J. Sekino Y, et al. Among authors: taniyama d. Anticancer Res. 2021 Sep;41(9):4287-4294. doi: 10.21873/anticanres.15233. Anticancer Res. 2021. PMID: 34475048
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
Babasaki T, Sentani K, Sekino Y, Kobayashi G, Thang Pham Q, Katsuya N, Akabane S, Taniyama D, Hayashi T, Shiota M, Oue N, Teishima J, Matsubara A, Yasui W. Babasaki T, et al. Among authors: taniyama d. Cancer Med. 2021 Aug;10(16):5574-5588. doi: 10.1002/cam4.4113. Epub 2021 Jul 9. Cancer Med. 2021. PMID: 34240817 Free PMC article.
75 results